News Eisai angry over thyroid cancer drug impasse in England Thyroid cancer drug falls through gap in NHS funding
News Patients denied thyroid cancer drug in England Eisai considers legal action over funding "black hole".
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
